Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Enhancing the value of clinical trials: the role of data sharing

Nature Reviews Cardiology volume 13, pages 629–630 (2016)Cite this article

Subjects

Sharing of data from clinical trials provides the opportunity to improve the value and integrity of data analyses, but there are risks, and the primary duty for responsible reporting should reside with the investigators.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Jones, C. W. et al. Non-publication of large randomized clinical trials: cross sectional analysis. BMJ 347, f6104 (2013).

    Article  Google Scholar 

  2. Institute of Medicine. Sharing clinical trial data: maximizing benefits, minimizing risk. (National Academies Press, 2015).

  3. Taichman, D. B. et al. Sharing clinical trial data — a proposal from the International Committee of Medical Journal Editors. N. Engl. J. Med. 374, 384–386 (2016).

    Article  Google Scholar 

  4. Academic Research Organization Consortium for Continuing Evaluation of Scientific Studies — Cardiovascular (ACCESS CV). Sharing data from cardiovascular clinical trials — a proposal. N. Engl. J. Med. 375, 407–409 (2016).

  5. International Consortium of Investigators for Fairness in Trial Data Sharing. Toward fairness in data sharing. N. Engl. J. Med. 375, 405–407 (2016).

  6. Ohman, E. M. & Roe, M. T. Explaining the unexpected: insights from the PLATelet inhibition and clinical Outcomes (PLATO) trial comparing ticagrelor and clopidogrel. Editorial on Serebruany “Viewpoint: Paradoxical excess mortality in the PLATO trial should be independently verified” (Thromb Haemost 2011; 105.5). Thromb. Haemost. 105, 763–765 (2011).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Duke Clinical Research Institute, 2400 Pratt Street, Durham, 27710, North Carolina, USA

    Christopher B. Granger & E. Magnus Ohman

Authors
  1. Christopher B. Granger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Magnus Ohman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christopher B. Granger.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Related links

Related links

FURTHER INFORMATION

Clinical Study Data Request

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Granger, C., Ohman, E. Enhancing the value of clinical trials: the role of data sharing. Nat Rev Cardiol 13, 629–630 (2016). https://doi.org/10.1038/nrcardio.2016.146

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrcardio.2016.146

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing